查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542535

全球间质干细胞市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Mesenchymal Stem Cells Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 234 Pages | 商品交期: 最快1-2个工作天内

价格

全球间质干细胞市场需求预计将从 2023 年的 31.8 亿美元达到 2032 年近 99.3 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 13.5%。

间质干细胞（MSC）是一种多功能成体干细胞，存在于骨髓、脂肪组织和脐带血等多种身体组织中。间质干细胞具有转化为骨骼、软骨、脂肪和肌肉细胞等不同细胞类型的卓越能力，在再生医学和组织工程领域具有巨大的潜力。除了分化能力之外，间质干细胞还表现出免疫调节特性，在调节免疫反应和促进组织修復和再生过程中发挥关键作用。这种独特的特征组合使它们成为治疗骨科损伤、心血管疾病或自体免疫疾病等多种疾病的有希望的候选药物。

市场动态

间质干细胞（MSC）市场受到塑造再生医学和细胞治疗格局的多种因素的推动。首先，人们对间质干细胞在组织修復、免疫调节和再生医学方面的治疗潜力的日益了解，推动了对基于间质干细胞的治疗各种疾病的需求，包括骨科疾病、自体免疫疾病和神经系统疾病。此外，慢性病、人口老化和生活方式相关疾病的盛行率不断上升，推动了对创新治疗方式的需求，这些方式有可能解决未满足的医疗需求并改善患者的治疗结果。此外，细胞培养技术、细胞分离方法和冷冻保存技术的进步使得基于间质干细胞的疗法的可扩展生产和临床转化成为可能，从而推动市场扩张和可及性。

此外，基于 MSC 的产品和疗法的监管批准和临床验证支持市场成长以及医疗保健提供者和患者的采用。此外，生物技术公司、学术研究机构和製药公司之间的策略合作、伙伴关係和投资推动了基于 MSC 的疗法的创新、产品开发和商业化，促进市场成长和竞争力。此外，增加对临床研究、临床前研究和转化医学计划的投资有助于间质干细胞市场的扩大和新型治疗应用的开发。然而，製造可扩展性、产品品质标准化和监管合规性等挑战可能会阻碍未来几年间充质干细胞市场的成长，因此需要继续努力解决这些障碍并释放基于间质干细胞的疗法在再生医学中的全部潜力和细胞疗法。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球间质干细胞市场的各个细分市场进行了包容性评估。间质干细胞产业的成长和趋势为这项研究提供了整体方法。

市场区隔

间质干细胞市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品和服务

  • 产品（细胞和细胞系、试剂盒、培养基和试剂、其他）
  • 服务

按工作流程

  • 细胞采购与分离
  • 培养与冷冻保存
  • 差异化
  • 表征

按类型

  • 自体
  • 同种异体

按隔离来源分类

  • 骨髓
  • 脐带血
  • 週边血
  • 输卵管
  • 胎儿肝臟
  • 肺
  • 脂肪组织

按指示

  • 骨骼和软骨修復
  • 心血管疾病
  • 发炎和免疫性疾病
  • 肝臟疾病
  • 癌症
  • 移植物抗宿主疾病
  • 其他的

按申请

  • 疾病建模
  • 药物开发与发现
  • 干细胞银行
  • 组织工程
  • 毒理学研究
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲间质干细胞市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。间质干细胞市场的主要参与者包括Thermo Fisher Scientific Inc.、Cell Applications Inc.、Axol Biosciences Ltd.、Cytori Therapeutics Inc.、STEMCELL Technologies、Cyagen Biosciences.、Celprogen Inc.、BrainStorm Cell Limited.、Stemedica Cell Technologies Technologies Technologies Technologies Technologies Technologies Technologies Inc.、 Merck KGaA (MilliporeSigma)、Lonza、PromoCell GmbH。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：间质干细胞 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品和服务分類的市场吸引力分析
    • 依工作流程进行市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按隔离来源进行的市场吸引力分析
    • 按指标进行的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球间质干细胞市场分析：依产品与服务分类

  • 按产品和服务分類的概述
  • 历史和预测数据
  • 按产品和服务分析
  • 产品（细胞和细胞系、试剂盒、培养基和试剂、其他）
  • 服务

第 6 章：全球间质干细胞市场分析：依工作流程

  • 按工作流程概述
  • 历史和预测数据
  • 按工作流程分析
  • 细胞采购与分离
  • 培养与冷冻保存
  • 差异化
  • 表征

第 7 章：全球间质干细胞市场分析：依类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 自体
  • 同种异体

第 8 章：全球间质干细胞市场分析：依隔离来源分类

  • 按隔离源分類的概述
  • 历史和预测数据
  • 按隔离源分析
  • 骨髓
  • 脐带血
  • 週边血
  • 输卵管
  • 胎儿肝臟
  • 肺
  • 脂肪组织

第 9 章：全球间质干细胞市场分析：依适应症分类

  • 按适应症概述
  • 历史和预测数据
  • 按指标分析
  • 骨骼和软骨修復
  • 心血管疾病
  • 发炎和免疫性疾病
  • 肝臟疾病
  • 癌症
  • 移植物抗宿主疾病
  • 其他的

第 10 章：全球间质干细胞市场分析：依应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 疾病建模
  • 药物开发与发现
  • 干细胞银行
  • 组织工程
  • 毒理学研究
  • 其他的

第 11 章：全球间质干细胞市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 12 章：间质干细胞公司的竞争格局

  • 间质干细胞市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 13 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cell Applications Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Axol Biosciences Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cytori Therapeutics Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • STEMCELL Technologies
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cyagen Biosciences.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Celprogen Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BrainStorm Cell Limited.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Stemedica Cell Technologies Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck KGaA (MilliporeSigma)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Lonza
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PromoCell GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR11219961

The global demand for Mesenchymal Stem Cells Market is presumed to reach the market size of nearly USD 9.93 Billion by 2032 from USD 3.18 Billion in 2023 with a CAGR of 13.5% under the study period 2024 - 2032.

Mesenchymal stem cells, or in short MSCs are a type of versatile adult stem cell present in various bodily tissues such as bone marrow, adipose tissue, and umbilical cord blood. With their remarkable ability to transform into different cell types like bone, cartilage, fat, and muscle cells, MSCs hold immense potential in the fields of regenerative medicine and tissue engineering. Beyond their differentiation capabilities, MSCs also exhibit immunomodulatory characteristics, playing a pivotal role in regulating immune responses and facilitating tissue repair and regeneration processes. This unique combination of traits has positioned them as promising candidates for treating a wide array of medical conditions, such as orthopedic injuries, cardiovascular diseases or autoimmune disorders.

MARKET DYNAMICS

The Mesenchymal Stem Cells (MSCs) market is propelled by several factors shaping the landscape of regenerative medicine and cell therapy. Firstly, the increasing understanding of MSCs' therapeutic potential in tissue repair, immunomodulation, and regenerative medicine drives the demand for MSC-based therapies for various medical conditions, including orthopedic disorders, autoimmune diseases, and neurological disorders. Additionally, the rising prevalence of chronic diseases, aging population, and lifestyle-related ailments fuel the need for innovative treatment modalities with the potential to address unmet medical needs and improve patient outcomes. Moreover, advancements in cell culture techniques, cell isolation methods, and cryopreservation technologies enable the scalable production and clinical translation of MSC-based therapies, driving market expansion and accessibility.

Furthermore, the regulatory approvals and clinical validation of MSC-based products and therapies support market growth and adoption by healthcare providers and patients. Additionally, strategic collaborations, partnerships, and investments among biotechnology companies, academic research institutions, and pharmaceutical companies drive innovation, product development, and commercialization of MSC-based therapies, fostering market growth and competitiveness. Furthermore, increasing investments in clinical research, preclinical studies, and translational medicine initiatives contribute to the expansion of the MSCs market and the development of novel therapeutic applications. However, challenges such as manufacturing scalability, standardization of product quality, and regulatory compliance may hinder the growth of the MSCs market in the next few years, necessitating continued efforts to address these hurdles and unlock the full potential of MSC-based therapies in regenerative medicine and cell therapy.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain Analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mesenchymal stem cells. The growth and trends of the mesenchymal stem cells industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the mesenchymal stem cells market report provides detailed data on the segments at the country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services

  • Products (Cells & Cell Lines, Kits, Media, & Reagents, Others)
  • Services

By Workflow

  • Cell Sourcing & Isolation
  • Culture & Cryopreservation
  • Differentiation
  • Characterization

By Type

  • Autologous
  • Allogeneic

By Source Of Isolation

  • Bone Marrow
  • Cord Blood
  • Peripheral Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Adipose Tissues

By Indication

  • Bone And Cartilage Repair
  • Cardiovascular Disease
  • Inflammatory And Immunological Diseases
  • Liver Diseases
  • Cancer
  • GvHD
  • Others

By Application

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Mesenchymal Stem Cells market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Mesenchymal Stem Cells market include Thermo Fisher Scientific Inc., Cell Applications Inc., Axol Biosciences Ltd., Cytori Therapeutics Inc, STEMCELL Technologies, Cyagen Biosciences., Celprogen Inc, BrainStorm Cell Limited., Stemedica Cell Technologies Inc, Merck KGaA (MilliporeSigma), Lonza, PromoCell GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MESENCHYMAL STEM CELLS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Services
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Type
    • 3.7.4 Market Attractiveness Analysis By Source Of Isolation
    • 3.7.5 Market Attractiveness Analysis By Indication
    • 3.7.6 Market Attractiveness Analysis By Application
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY PRODUCT & SERVICES

  • 5.1 Overview by Product & Services
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product & Services
  • 5.4 Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Historic and Forecast Sales by Regions
  • 5.5 Services Historic and Forecast Sales by Regions

6 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY WORKFLOW

  • 6.1 Overview by Workflow
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Workflow
  • 6.4 Cell Sourcing & Isolation Historic and Forecast Sales by Regions
  • 6.5 Culture & Cryopreservation Historic and Forecast Sales by Regions
  • 6.6 Differentiation Historic and Forecast Sales by Regions
  • 6.7 Characterization Historic and Forecast Sales by Regions

7 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Type
  • 7.4 Autologous Historic and Forecast Sales by Regions
  • 7.5 Allogeneic Historic and Forecast Sales by Regions

8 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY SOURCE OF ISOLATION

  • 8.1 Overview by Source Of Isolation
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Source Of Isolation
  • 8.4 Bone Marrow Historic and Forecast Sales by Regions
  • 8.5 Cord Blood Historic and Forecast Sales by Regions
  • 8.6 Peripheral Blood Historic and Forecast Sales by Regions
  • 8.7 Fallopian Tube Historic and Forecast Sales by Regions
  • 8.8 Fetal Liver Historic and Forecast Sales by Regions
  • 8.9 Lung Historic and Forecast Sales by Regions
  • 8.10. Adipose Tissues Historic and Forecast Sales by Regions

9 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY INDICATION

  • 9.1 Overview by Indication
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Indication
  • 9.4 Bone And Cartilage Repair Historic and Forecast Sales by Regions
  • 9.5 Cardiovascular Disease Historic and Forecast Sales by Regions
  • 9.6 Inflammatory And Immunological Diseases Historic and Forecast Sales by Regions
  • 9.7 Liver Diseases Historic and Forecast Sales by Regions
  • 9.8 Cancer Historic and Forecast Sales by Regions
  • 9.9 GvHD Historic and Forecast Sales by Regions
  • 9.10. Others Historic and Forecast Sales by Regions

10 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY APPLICATION

  • 10.1 Overview by Application
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Application
  • 10.4 Disease Modelling Historic and Forecast Sales by Regions
  • 10.5 Drug Development & Discovery Historic and Forecast Sales by Regions
  • 10.6 Stem Cell Banking Historic and Forecast Sales by Regions
  • 10.7 Tissue Engineering Historic and Forecast Sales by Regions
  • 10.8 Toxicology Studies Historic and Forecast Sales by Regions
  • 10.9 Others Historic and Forecast Sales by Regions

11 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Regional Outlook
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE MESENCHYMAL STEM CELLS COMPANIES

  • 12.1. Mesenchymal Stem Cells Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF MESENCHYMAL STEM CELLS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Thermo Fisher Scientific Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Cell Applications Inc.
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Axol Biosciences Ltd.
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Cytori Therapeutics Inc
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. STEMCELL Technologies
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Cyagen Biosciences.
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Celprogen Inc
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. BrainStorm Cell Limited.
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Stemedica Cell Technologies Inc
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Merck KGaA (MilliporeSigma)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Lonza
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. PromoCell GmbH
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Services (USD MN)
  • Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Workflow (USD MN)
  • Cell Sourcing & Isolation Market Sales by Geography (USD MN)
  • Culture & Cryopreservation Market Sales by Geography (USD MN)
  • Differentiation Market Sales by Geography (USD MN)
  • Characterization Market Sales by Geography (USD MN)
  • Analysis by Type (USD MN)
  • Autologous Market Sales by Geography (USD MN)
  • Allogeneic Market Sales by Geography (USD MN)
  • Analysis by Source Of Isolation (USD MN)
  • Bone Marrow Market Sales by Geography (USD MN)
  • Cord Blood Market Sales by Geography (USD MN)
  • Peripheral Blood Market Sales by Geography (USD MN)
  • Fallopian Tube Market Sales by Geography (USD MN)
  • Fetal Liver Market Sales by Geography (USD MN)
  • Lung Market Sales by Geography (USD MN)
  • Adipose Tissues Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Bone And Cartilage Repair Market Sales by Geography (USD MN)
  • Cardiovascular Disease Market Sales by Geography (USD MN)
  • Inflammatory And Immunological Diseases Market Sales by Geography (USD MN)
  • Liver Diseases Market Sales by Geography (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • GvHD Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Disease Modelling Market Sales by Geography (USD MN)
  • Drug Development & Discovery Market Sales by Geography (USD MN)
  • Stem Cell Banking Market Sales by Geography (USD MN)
  • Tissue Engineering Market Sales by Geography (USD MN)
  • Toxicology Studies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Mesenchymal Stem Cells Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Mesenchymal Stem Cells Report
  • Market Research Process
  • Market Research Methodology
  • Global Mesenchymal Stem Cells Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Services
  • Market Attractiveness Analysis by Workflow
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Source Of Isolation
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Services (USD MN)
  • Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Workflow (USD MN)
  • Cell Sourcing & Isolation Market Sales by Geography (USD MN)
  • Culture & Cryopreservation Market Sales by Geography (USD MN)
  • Differentiation Market Sales by Geography (USD MN)
  • Characterization Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Autologous Market Sales by Geography (USD MN)
  • Allogeneic Market Sales by Geography (USD MN)
  • Global Market Analysis by Source Of Isolation (USD MN)
  • Bone Marrow Market Sales by Geography (USD MN)
  • Cord Blood Market Sales by Geography (USD MN)
  • Peripheral Blood Market Sales by Geography (USD MN)
  • Fallopian Tube Market Sales by Geography (USD MN)
  • Fetal Liver Market Sales by Geography (USD MN)
  • Lung Market Sales by Geography (USD MN)
  • Adipose Tissues Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Bone And Cartilage Repair Market Sales by Geography (USD MN)
  • Cardiovascular Disease Market Sales by Geography (USD MN)
  • Inflammatory And Immunological Diseases Market Sales by Geography (USD MN)
  • Liver Diseases Market Sales by Geography (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • GvHD Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Disease Modelling Market Sales by Geography (USD MN)
  • Drug Development & Discovery Market Sales by Geography (USD MN)
  • Stem Cell Banking Market Sales by Geography (USD MN)
  • Tissue Engineering Market Sales by Geography (USD MN)
  • Toxicology Studies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.